SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-18-000220
Filing Date
2018-02-14
Accepted
2018-02-14 08:53:14
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e617670_sc13ga-windtree.htm SC 13G/A 137777
  Complete submission text file 0001193805-18-000220.txt   139621
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52027 | Film No.: 18607465
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A